Loading clinical trials...
Loading clinical trials...
Hemostatic Profiles Associated With Use of Aromatase Inhibitors and Tamoxifen in Women With Breast Cancer : a Prospective Cohort Study
Conditions
Locations
1
Switzerland
Geneva University Hospitals
Geneva, Switzerland
Start Date
April 1, 2017
Primary Completion Date
February 28, 2020
Completion Date
February 28, 2020
Last Updated
April 9, 2020
NCT07191730
NCT06797635
NCT06312176
NCT06189313
NCT07003841
NCT07015905
Lead Sponsor
University Hospital, Geneva
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions